{"entity":{"type":"insider","cik":"0001642996","url":"/insider/0001642996","json_url":"/insider/0001642996.json","name":"CHEN JIN-LONG","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":20,"first":"2019-11-04","last":"2023-01-18","span_basis":"filed_date"},"name_variants":[{"name":"CHEN JIN-LONG","source":"filing","n_filings":20,"first_seen":"2019-11-04","last_seen":"2023-01-18"}],"transactions":[{"id":8572969,"accession":"0001209191-23-003702","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-003702","line_url":"/filing/0001209191-23-003702#line-2","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85082.0,"shares_display":"85,082","price_per_share":5.1516,"price_display":"5.15","price_state":"stated","total_value":438308.4312,"total_display":"438,308.43","total_whole":"438,308","shares_owned_after":908893.0,"shares_owned_after_display":"908,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-18","scope":"insider"},{"id":5538349,"accession":"0001209191-21-068466","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-068466","line_url":"/filing/0001209191-21-068466#line-3","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":18.6,"price_display":"18.60","price_state":"stated","total_value":279000.0,"total_display":"279,000.00","total_whole":"279,000","shares_owned_after":908893.0,"shares_owned_after_display":"908,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-07","filed_date":"2021-12-07","scope":"insider"},{"id":5538345,"accession":"0001209191-21-068466","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-068466","line_url":"/filing/0001209191-21-068466#line-2","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":18.21,"price_display":"18.21","price_state":"stated","total_value":273150.0,"total_display":"273,150.00","total_whole":"273,150","shares_owned_after":854449.0,"shares_owned_after_display":"854,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-07","scope":"insider"},{"id":4588165,"accession":"0001209191-21-064853","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-064853","line_url":"/filing/0001209191-21-064853","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":19.725,"price_display":"19.72","price_state":"stated","total_value":591750.0,"total_display":"591,750.00","total_whole":"591,750","shares_owned_after":884449.0,"shares_owned_after_display":"884,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-16","scope":"insider","n_lines":2},{"id":4143424,"accession":"0001209191-21-060364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-060364","line_url":"/filing/0001209191-21-060364#line-2","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":20.14,"price_display":"20.14","price_state":"stated","total_value":302100.0,"total_display":"302,100.00","total_whole":"302,100","shares_owned_after":899449.0,"shares_owned_after_display":"899,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-12","filed_date":"2021-10-13","scope":"insider"},{"id":4143419,"accession":"0001209191-21-060364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060364","line_url":"/filing/0001209191-21-060364#line-1","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":20.41,"price_display":"20.41","price_state":"stated","total_value":306150.0,"total_display":"306,150.00","total_whole":"306,150","shares_owned_after":914449.0,"shares_owned_after_display":"914,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-11","filed_date":"2021-10-13","scope":"insider"},{"id":5478532,"accession":"0001209191-21-056083","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-056083","line_url":"/filing/0001209191-21-056083","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":25.659455333333334,"price_display":"25.66","price_state":"stated","total_value":384891.83,"total_display":"384,891.83","total_whole":"384,892","shares_owned_after":932486.0,"shares_owned_after_display":"932,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-14","scope":"insider","n_lines":2},{"id":5478527,"accession":"0001209191-21-056083","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-056083","line_url":"/filing/0001209191-21-056083","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":26.027606666666667,"price_display":"26.03","price_state":"stated","total_value":390414.1,"total_display":"390,414.10","total_whole":"390,414","shares_owned_after":944619.0,"shares_owned_after_display":"944,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-14","scope":"insider","n_lines":3},{"id":4895745,"accession":"0001209191-21-050981","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-050981","line_url":"/filing/0001209191-21-050981#line-4","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":23.15,"price_display":"23.15","price_state":"stated","total_value":347250.0,"total_display":"347,250.00","total_whole":"347,250","shares_owned_after":959449.0,"shares_owned_after_display":"959,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-10","filed_date":"2021-08-11","scope":"insider"},{"id":4895737,"accession":"0001209191-21-050981","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-050981","line_url":"/filing/0001209191-21-050981","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":24.464826,"price_display":"24.46","price_state":"stated","total_value":366972.39,"total_display":"366,972.39","total_whole":"366,972","shares_owned_after":981718.0,"shares_owned_after_display":"981,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-11","scope":"insider","n_lines":3},{"id":5332759,"accession":"0001209191-21-029913","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-029913","line_url":"/filing/0001209191-21-029913#line-1","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":27.62,"price_display":"27.62","price_state":"stated","total_value":690500.0,"total_display":"690,500.00","total_whole":"690,500","shares_owned_after":920005.0,"shares_owned_after_display":"920,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-04","scope":"insider"},{"id":4727883,"accession":"0001209191-21-026503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-026503","line_url":"/filing/0001209191-21-026503#line-1","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":24.65,"price_display":"24.65","price_state":"stated","total_value":616250.0,"total_display":"616,250.00","total_whole":"616,250","shares_owned_after":945005.0,"shares_owned_after_display":"945,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-13","scope":"insider"},{"id":4774563,"accession":"0001209191-21-016231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-016231","line_url":"/filing/0001209191-21-016231#line-1","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":26.66,"price_display":"26.66","price_state":"stated","total_value":666500.0,"total_display":"666,500.00","total_whole":"666,500","shares_owned_after":970005.0,"shares_owned_after_display":"970,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":4258884,"accession":"0001209191-21-011253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011253","line_url":"/filing/0001209191-21-011253#line-1","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":28.75,"price_display":"28.75","price_state":"stated","total_value":718750.0,"total_display":"718,750.00","total_whole":"718,750","shares_owned_after":995005.0,"shares_owned_after_display":"995,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":4772310,"accession":"0001209191-21-002374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-002374","line_url":"/filing/0001209191-21-002374","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":29.284652,"price_display":"29.28","price_state":"stated","total_value":732116.3,"total_display":"732,116.30","total_whole":"732,116","shares_owned_after":870375.0,"shares_owned_after_display":"870,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-06","scope":"insider","n_lines":2},{"id":2479582,"accession":"0001209191-20-063799","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-063799","line_url":"/filing/0001209191-20-063799","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":28.011036,"price_display":"28.01","price_state":"stated","total_value":700275.9,"total_display":"700,275.90","total_whole":"700,276","shares_owned_after":908879.0,"shares_owned_after_display":"908,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider","n_lines":3},{"id":2444959,"accession":"0001209191-20-056934","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-056934","line_url":"/filing/0001209191-20-056934#line-1","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":17.7,"price_display":"17.70","price_state":"stated","total_value":442500.0,"total_display":"442,500.00","total_whole":"442,500","shares_owned_after":920005.0,"shares_owned_after_display":"920,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-04","scope":"insider"},{"id":3018539,"accession":"0001209191-20-054708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-054708","line_url":"/filing/0001209191-20-054708#line-1","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":17.02,"price_display":"17.02","price_state":"stated","total_value":425500.0,"total_display":"425,500.00","total_whole":"425,500","shares_owned_after":945005.0,"shares_owned_after_display":"945,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-12","filed_date":"2020-10-13","scope":"insider"},{"id":2042156,"accession":"0001209191-20-049387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-049387","line_url":"/filing/0001209191-20-049387","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":17.833164,"price_display":"17.83","price_state":"stated","total_value":445829.1,"total_display":"445,829.10","total_whole":"445,829","shares_owned_after":977618.0,"shares_owned_after_display":"977,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-03","scope":"insider","n_lines":2},{"id":2077172,"accession":"0001209191-20-046128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-046128","line_url":"/filing/0001209191-20-046128#line-1","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":19.02,"price_display":"19.02","price_state":"stated","total_value":475500.0,"total_display":"475,500.00","total_whole":"475,500","shares_owned_after":995005.0,"shares_owned_after_display":"995,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-10","filed_date":"2020-08-11","scope":"insider"},{"id":3166977,"accession":"0001209191-20-040351","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-040351","line_url":"/filing/0001209191-20-040351","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":18.9091132,"price_display":"18.91","price_state":"stated","total_value":472727.83,"total_display":"472,727.83","total_whole":"472,728","shares_owned_after":1027268.0,"shares_owned_after_display":"1,027,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider","n_lines":2},{"id":2287224,"accession":"0001209191-20-037406","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-037406","line_url":"/filing/0001209191-20-037406","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":21.64664,"price_display":"21.65","price_state":"stated","total_value":541166.0,"total_display":"541,166.00","total_whole":"541,166","shares_owned_after":1045005.0,"shares_owned_after_display":"1,045,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-17","scope":"insider","n_lines":2},{"id":3294693,"accession":"0001209191-20-002910","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-20-002910","line_url":"/filing/0001209191-20-002910#line-9","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18641.0,"shares_display":"18,641","price_per_share":17.9501,"price_display":"17.95","price_state":"stated","total_value":334607.8141,"total_display":"334,607.81","total_whole":"334,608","shares_owned_after":1068443.0,"shares_owned_after_display":"1,068,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-09","filed_date":"2020-01-09","scope":"insider"},{"id":3294686,"accession":"0001209191-20-002910","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-002910","line_url":"/filing/0001209191-20-002910","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16034.0,"shares_display":"16,034","price_per_share":17.9798,"price_display":"17.98","price_state":"stated","total_value":288288.1132,"total_display":"288,288.11","total_whole":"288,288","shares_owned_after":996693.0,"shares_owned_after_display":"996,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-09","scope":"insider","n_lines":2},{"id":3294668,"accession":"0001209191-20-002910","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-002910","line_url":"/filing/0001209191-20-002910#line-2","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16090.0,"shares_display":"16,090","price_per_share":18.2024,"price_display":"18.20","price_state":"stated","total_value":292876.616,"total_display":"292,876.62","total_whole":"292,877","shares_owned_after":996693.0,"shares_owned_after_display":"996,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-09","scope":"insider"},{"id":8728725,"accession":"0001209191-19-055021","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-055021","line_url":"/filing/0001209191-19-055021#line-7","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10986.0,"shares_display":"10,986","price_per_share":12.2605,"price_display":"12.26","price_state":"stated","total_value":134693.853,"total_display":"134,693.85","total_whole":"134,694","shares_owned_after":996693.0,"shares_owned_after_display":"996,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-04","filed_date":"2019-11-04","scope":"insider"},{"id":8728719,"accession":"0001209191-19-055021","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-055021","line_url":"/filing/0001209191-19-055021#line-5","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11403.0,"shares_display":"11,403","price_per_share":13.2881,"price_display":"13.29","price_state":"stated","total_value":151524.2043,"total_display":"151,524.20","total_whole":"151,524","shares_owned_after":924943.0,"shares_owned_after_display":"924,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-01","filed_date":"2019-11-04","scope":"insider"},{"id":8728712,"accession":"0001209191-19-055021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-055021","line_url":"/filing/0001209191-19-055021#line-2","is_derivative":false,"issuer_cik":"0001426332","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001426332","owner_cik":"0001642996","owner_name":"CHEN JIN-LONG","owner_display_name":"CHEN JIN-LONG","owner_url":"/insider/0001642996","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28376.0,"shares_display":"28,376","price_per_share":12.9886,"price_display":"12.99","price_state":"stated","total_value":368564.5136,"total_display":"368,564.51","total_whole":"368,565","shares_owned_after":924943.0,"shares_owned_after_display":"924,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001426332","name":"NGM BIOPHARMACEUTICALS INC","url":"/issuer/0001426332","role":"Director, Officer (Chief Scientific Officer)","n_filings":20,"first_seen":"2019-11-04","last_seen":"2023-01-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001642996","retrieved_at":"2026-08-27T07:25:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}